How many clinical trials are tracked for osteopenia?

38 trials are tracked, 3 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

Log in / Sign up

Osteopenia

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for osteopenia

38 trials tracked for osteopenia: 14 in phase 3 or 4 and 3 with published results. The most-cited published study has 343 citations.

38Trials tracked

14Phase 3 & 4

0Recruiting

3With published results

Phase distribution

Phase 4 4 Phase 3 10 Phase 2 6 Phase 1 7 Other / NA 11

Phase 3 Extension Study to Evaluate the Long Term Safety and Efficacy of Denosumab in the Treatment of Osteoporosis Completed · 343 cited
Phase 3 Using Soy Estrogens to Prevent Bone Loss and Other Menopausal Symptoms Completed · 179 cited
Phase 3 Heartland Osteoporosis Prevention Study Completed · 22 cited
Phase 4 Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption? Completed
Phase 4 Does Treatment of Hypovitaminosis D Increase Calcium Absorption? Completed
Phase 4 Switch From Tenofovir to Raltegravir for Low Bone Mineral Density Completed

Show 32 more trials

Phase 4 Alendronate Prevents Microarchitectural Deterioration of Trabecular Bone in Early Postmenopausal Women Completed
Phase 3 Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Completed
Phase 3 AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer Completed
Phase 3 Zoledronic Acid in the Prevention of Bone Loss in Postmenopausal Women With Osteopenia, 45 Years of Age and Older Completed
Phase 3 A Randomized, Double-Blind Study to Compare the Efficacy of Treatment With Denosumab Versus Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density. Completed
Phase 3 Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With Osteoporosis Completed
Phase 3 A Multi-Center, Randomized, Open-Label Study to Assess the Immunogenicity and Safety of Denosumab in Pre-filled Syringe Compared to Vial in Subjects With Low Bone Mineral Density Completed
Phase 3 Study of the Effect of Once a Week Risedronate on the Microstructure of Tibia and Radius Using a New Scanning Method Completed
Phase 2 Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation Completed
Phase 2 Bone Loss and Immune Reconstitution in HIV/AIDS (BLIR-HIV) Completed
Phase 2 A Study of Oral Recombinant Salmon Calcitonin (rsCT) to Prevent Postmenopausal Osteoporosis Completed
Phase 2 Denosumab in Treating Patients With Bone Loss Due to Donor Stem Cell Transplant Completed
Phase 2 Effect of Growth Hormone on Bone Metabolism in Anorexia Nervosa Completed
Phase 2 Adding Phosphorus to Osteoporosis Drug Treatment Completed
Phase 1 Melatonin Osteoporosis Prevention Study Completed
Phase 1 A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Romosozumab (AMG 785) Completed
Phase 1 A First-in-human Study Evaluating Romosozumab (AMG 785) in Healthy Men and Postmenopausal Women Completed
Phase 1 A Study to Evaluate the Effect of Romosozumab (AMG 785) on Bone Quality of the Forearm in Postmenopausal Women With Low Bone Mass Completed
Phase 1 Safety And Tolerability Study Of RN564 In Women With Osteopenia And Healthy Men. Completed
Phase 1 A Single-dose Study Evaluating Romosozumab (AMG 785) in Healthy Postmenopausal Japanese and Non-Japanese Women Completed
Phase 1 Effect of a Ghrelin Receptor Agonist on Muscle and Bone Completed
N/A Efficacy of Potassium Citrate in the Treatment of Postmenopausal Osteopenia Completed
N/A Study Evaluating ASTRA TECH Implant System, OsseoSpeed™ Implants in the Upper Jaw in Women With Osteoporosis Completed
N/A Incidence of HANA Conditions in HIV-infected Individuals Completed
N/A Models of Primary Osteoporosis Screening in Male Veterans Completed
N/A Effects of Physical Training on Bone Turnover and Quality of Life in Osteopenic Postmenopausal Women. Completed
N/A Wearable Vibration Device to Prevent Bone Loss in Postmenopausal Women--Aim 2 Completed
N/A IGF-1 and Bone Loss in Women With Anorexia Nervosa Completed
N/A Prevention of Post Operative Bone Loss in Children Completed
N/A Comparative Effects of Moxonidine on Bone Metabolism, Vascular and Cellular Aging in Hypertensive Postmenopausal Women Completed
N/A Study of Growth Hormone and Bone in Obesity Completed
N/A Texture Analysis for Postmenopausal Osteoporosis Completed

Showing the 38 most-cited and recently-updated of 38 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

Questions about osteopenia

Will taking glucocorticoids for lupus make my osteopenia worse over time?

Taking glucocorticoids for lupus is a major risk factor that can worsen osteopenia and lead to osteoporosis over time.

Full answer →

Can a chest CT scan show if my bone density is low enough for osteopenia?

A chest CT scan can detect low bone density, but it is not the standard test for diagnosing osteopenia. Doctors usually use a DEXA scan for that specific diagnosis, though chest CT can help identify risk or monitor changes.

Full answer →